Please login to the form below

Not currently logged in
Email:
Password:

Genentech

This page shows the latest Genentech news and features for those working in and with pharma, biotech and healthcare.

Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy

Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy

Genentech’s Evrysdi (risdiplam), a treatment for spinal muscular atrophy (SMA), has been given an extended approved by the US Food and Drug Administration (FDA) to include babies under two months ... Levi Garraway, Genentech’s chief medical officer

Latest news

More from news
Approximately 16 fully matching, plus 250 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....